Objective: To better characterize the genetic factors, implicated in oxidative pathway, determining susceptibility to inflammatory bowel disease (IBD), we assessed for the first time the potential role of NOS2A, HIF1A and NFKB1 polymorphisms on the risk of developing IBD in Moroccan population.
Introduction:
Inflammatory bowel disease (IBD), a chronic and relapsing-remitting disorder of the gastrointestinal tract, encompasses Crohn's disease (CD) and ulcerative colitis (UC).
IBD was thought to be a western disease, with higher prevalence reported in developed countries [1] . However, during the last few decades, incidence rates of the two major forms of IBD have been increasing in developing countries [2] , including Morocco.
Chronic intestinal inflammation is a hallmark of both disorders, and is believed to result from a number of abnormal conditions. The involvement of oxidative damage in IBD development has been thoroughly documented. Oxidative stress mainly contributes to aberrant inflammatory responses of intestinal cells to commensal bacteria and dietary antigens. During IBD, activated leukocytes generate a wide spectrum of proinflammatory cytokines, in addition to excessive oxidative reactions that alter the redox equilibrium within the gut mucosa.
Therefore, capacity to maintain inflammation by induction of transcription factors and redoxsensitive signaling pathways may influence the occurrence and severity of the disease [3] .Induction of inducible nitric oxide synthase (iNOS) was reported to play a key role in oxidative stress-induced inflammation [4] . The genetic polymorphisms of the NOS2A (nitric oxide synthase) gene have been proposed to be involved in IBD aetiology [5] .Two functionally relevant polymorphisms located at NOS2A gene promoter region were reported, the first one is a highly polymorphic pentanucleotide (CCTTT)n microsatellite repeat which is important in the regulation of NOS2A transcription [6] . The second one is located at the proximal promoter region and consists of an insertion/deletion of one TAAA repeat [7] .
Perpetuation of inflammation is also mediated by cellular stress responses of inflammatory cells that produce soluble mediators and reactive species which act by further inducing changes in transcription factors, among which hypoxia-inducible factor-1α (HIF-1α) and nuclear factor κ B (NF-κB) [8] . HIF-1-α is a key regulator of cellular response to hypoxia, the gene encoding the HIF-1α subunit (HIF1A) carries a common missense mutation, A588T
(G>A, rs11549467), that has been related to increased trans-activation capacity [9] . The involvement of HIF-1-α in the enhancement of the inflammatory response was demonstrated, elevated levels of HIF-1-α in biopsies of primary lesions of patients confirmed its role in inflammatory diseases [10] . HIF-1-α has been shown to induce the secretion of inflammatory mediators by indirect signaling through NF-kB-mediated cytokine and chemokine secretion [11] .
NF-κB is activated during inflammation, giving rise to induction of gene expression of several genes involved in mucosal inflammation such as cytokines (TNFA, IL6, IL1β...), Cox-2, and NOS2A [12] [13] .A functional NFKB1 promoter polymorphism, consisting of a common insertion/deletion (94ins/delATTG) that seems to affect promoter activity of the NFKB1 gene and differential nuclear protein binding [14] , was associated to the risk of CD [15] and UC [14] .
In search of relevant gene polymorphisms related to oxidative stress signaling that are involved in IBD development, we explored the association of HIF1A_rs11549467, NFKB1_rs28362491 NOS2A(CCTTT)n_rs3833912 and NOS2A(TAAA)_rs12720460
polymorphisms with IBD (CD and UC) in a Moroccan population.
Material and methods
Study population. Peripheral blood was obtained from 311 healthy unrelated blood donors.
199 patients diagnosed with IBD at the CHU Ibn Rochd Hospital (Casablanca, Morocco)
were included in this study. The diagnosis of CD or UC was established according to conventional endoscopic, clinical, histological and radiological criteria as previously described [14] ; [16] ; [17] .CD phenotype was classified according to the Montreal classification [18] . UC anatomic location was subgrouped using Paris classification [19 The NOS2A (TAAA)n_rs12720460 and (CCTTT)n_rs3833912genotyping was performed using a polymerase chain reaction (PCR)-based method combined with fluorescent technology as previously described [20] . Forward and reverse primers were: TaqMan SNP genotyping assays (Applied Biosystems, Foster City, CA, USA) as previously described [21] ; [22] . PCR was carried out in a total reaction volume of 5 μ l with the following amplification protocol: initial denaturation at 95°C for 3 min followed by 50 cycles 
Statistical analysis
Genotype and allele distributions among patients with CD, UC and IBD versus healthy controls were compared using the χ 2 test or Fisher test as appropriate. Odds ratios (ORs) with a confidence interval (CI) of 95% were assessed to measure the strength of association. 
Results
Hundred ninety-nine patients with IBD (136 CD; 63 UC) and 308 control subjects were included in this study. The success rates of genotyping assays ranged between 95 and 100%.
Baseline demographic and clinical characteristics of cases are presented in a previous report [36] .
HIF1A (G/A) rs11549467 and NFKB1-94ins/delATTG (rs28362491) polymorphisms
In both patients and controls, the genotype distribution of examined polymorphisms complied with the Hardy-Weinberg expectations.
In order to study associations of HIF1A (rs11549467) and NFKB1 (rs28362491) variants in IBD overall and in CD and UC in particular, the distribution of polymorphic alleles was assessed. Genotype and allele frequencies are given in Tables 1 and 2 .
The analysis of both HIF1A (rs11549467) and NFKB1 (rs28362491) polymorphisms distribution among patients and controls did not reveal any statistically significant association, both in terms of allele and genotype frequencies. Similarly, we did not observe any effect on disease risk when Genetic models were assessed ( Table 2) .
NOS2A (TAAA)n and (CCTTT)n repeat microsatellite polymorphisms
We explored the potential influence of NOS2A polymorphisms on the susceptibility to IBD in the Moroccan population. Tables 3 and 4 However, it should be noted that after Bonferroni correction by the number of comparisons, none of the observed associations remained significant in all patient groups.
We further analyzed the distribution of TAAA insertion/deletion polymorphism of NOS2A gene in our population. In this regard, no statistically significant allele or genotype differences were observed between IBD patients and controls (Table 5 ). Nor were significant differences between stratified CD and UC patients when compared to controls.
Discussion
IBD is an inflammatory disease resulting from a compound effect of a number of abnormal conditions. Genetic factors may play a pivotal role in the development of IBD. In this regard, we explored the potential contribution of genetic polymorphisms of genes related to oxidative pathway to the risk of IBD development. Our attention was focused on functionally relevant polymorphisms located in the NOS2A and NFKB1genes, and a common missense mutation of HIF1A gene.
We found differential distribution of (CCTTT)n microsatellite repeats between patients and controls; namely the (CCTTT)8 and (CCTTT) 14 repeats for IBD, the (CCTTT)8 for CD and the (CCTTT)7, (CCTTT) 11 , (CCTTT) 14 and (CCTTT) 15 repeats for UC patients. As for Caucasians, the most common allele observed in our population was the 12 repeats instead of 10 and 11 repeats for Northwestern Colombians [20] .To our knowledge only two reports investigated the involvement of NOS2A gene polymorphisms in IBD etiology. Concordantly to our results, M C. Martín et al., evidenced the influence of the inducible nitric oxide synthase (CCTTT)n microsatellite repeats on UC risk [5] . However, in contrast to our finding J. Oliver et al., demonstrated no tendency toward an association with IBD predisposition [23] .
Polymorphisms of NOS2A have also been involved in other autoimmune diseases such multiple sclerosis and rheumatoid arthritis [24] , [25] .
In terms of functional relevance, CCTTT polymorphic markers have been described to affect nitric oxide synthase (NOS) transcription [6] . The involvement of the inducible (calciumindependent) isoform, iNOS in inflammation has been largely demonstrated [26] and is directly related to the large amounts of NO produced by the enzyme after transcriptional induction and the injurious levels of RNS generated by activated leukocytes, macrophages and epithelial cells in the intestinal mucosa [27] . The overexpression of iNOS during active IBD is characterized by elevated rectal NO levels [28] .Biopsies of UC-active patients demonstrate higher iNOS transcripts and enzyme levels as compared to controls or healthy relatives [29] . It was also demonstrated that in UC, greatly increased production of iNOSderived NO reacts with tyrosine leading to production of nitrotyrosine which is associated with infiltration of neutrophils in the epithelium [30] [31] .
In the other hand, the present study sought to assess the association of HIF1A (G/A) rs11549467 and NFKB1-94ins/delATTG (rs28362491) polymorphisms with IBD among Moroccan patients. Data on association of these genes with IBD in the North African population are currently lacking. Our results suggest that the studied NFKB1 gene variation do not influence susceptibility to IBD (CD and UC) in the cohort tested herein. Our findings are in accordance with previous investigations analyzing Spanish [32] British [33] and German populations [34] . In contrast, an association of the -94ins/delATTG polymorphism with UC was demonstrated in a North American population [14] . These discrepant results may have been caused by clinical, population and genetic differences in addition to ethnic origin heterogeneity.
In addition, the present case-control study could not establish a role for HIF1A (G/A) rs11549467 polymorphism in the pathogenesis of both CD and UC and also found no evidence for disease risk when evaluating genetic models. This later polymorphism was shown to be associated with autoimmune diseases such as systemic sclerosis [35] , however no investigation has assessed its involvement in IBD etiology.
Conclusion
Our results suggest although not formally demonstrate that, variation in the distribution of CCTTT repeats in the NOS2A gene may contribute to IBD development in the Moroccan population. Additionally, our data do not support a role for the NFKB1and HIF1A polymorphisms in the pathogenesis of IBD. Allelic frequencies of (CCTTT)n microsatellite polymorphism of NOS2A gene for CD, UC patients and healthy controls. 
